Clinical Trials

30 enrolled

Surgery

NCT07590570 2026-05-15

The Association of Lunula Status With the Efficacy and Safety of Neoadjuvant Therapy in Breast Cancer

Active not recruiting

188 enrolled

Breast Cancer Invasive

NCT07567573 2026-05-05

retroESGO ov1

11,383 enrolled

Ovarian Neoplasms, Postoperative Complications, Recurrence, Neoplasm, Residual

NCT07475923 2026-04-16

Molecular Surveillance In Early Breast Cancer Using The Tumor-Informed ctDNA Assay Myriad Genetics Precise MRD Test; A Prospective Observational Multicenter Study (The MRD Molecular Surveillance Study)

Withdrawn

Breast Neoplasms

NCT06405321 2026-01-14

Conversion or Neoadjuvant Therapy in Hepatocellular Carcinoma

2,000 enrolled

Carcinoma, Hepatocellular

NCT04908696 2025-12-04

Clinical Treatments in Specialized Diseases of Laryngeal Carcinoma (LC) and Hypopharyngeal Carcinoma (HPC)

1,000 enrolled

Head & Neck

Hypopharyngeal Neoplasms, Laryngeal Neoplasms

NCT07054086 2025-07-08

Patient Derived Organoids (PDOs) to Observe the Clinical Consistency of Personalized Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma

30 enrolled

Esophageal Neoplasms

NCT04089748 2025-06-06

BoBCaT

293 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT02420509 2025-06-04

Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis

Terminated

2 enrolled

Tumor-Agnostic

Neoplasms

NCT06889402 2025-03-21

Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy

600 enrolled

Esophageal Squamous Cell Carcinoma, Pathologic Complete Response, Esophageal Neoplasms, Recurrence

NCT06447532 2025-03-12

INFLAMMATE

Enrolling by invitation

4,500 enrolled

Breast Neoplasms, Inflammation

NCT06868693 2025-03-11

PEACE

240 enrolled

Pancreatic Neoplasms

NCT02395367 2025-03-07

POROMS

30,000 enrolled

Head & Neck

Head and Neck Neoplasms, Postoperative Complications

NCT06792149 2025-01-24

Prediction of Drug Response in Gastric Cancer Based on 3D Bioprinting

60 enrolled

Stomach Neoplasms

NCT06752135 2024-12-30

HRCC1

Terminated

97 enrolled

Uterine Cervical Neoplasms

NCT06630481 2024-10-08

CAP with NAT

462 enrolled

Pancreatic Neoplasms

NCT06613308 2024-09-25

Association Between Microbiome and the Efficacy and Safety of PD-1/PD-L1 Blockade in Resectable NSCLC

20 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06556355 2024-08-16

Anastomotic Leaks in Esophageal Squamous Cell Carcinoma Patients After Trimodal Therapy

218 enrolled

Esophageal Neoplasms, Anastomotic Leak

NCT06451393 2024-06-11

Predicting Gastric Cancer Response to Chemo With Multimodal AI Model

500 enrolled

Stomach Neoplasms

NCT06369480 2024-04-17

Prognostic Factors for Survival in Patients With Cholangiocarcinoma

2,000 enrolled

Cholangiocarcinoma

NCT06325423 2024-03-26

Predicting Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer

50 enrolled

Muscle-Invasive Bladder Carcinoma

NCT06304922 2024-03-12

BRCA 1/2 Status as a Predictive Factor to Response to Platinum Based Chemotherapy in Cancer Ovary

45 enrolled

Ovarian Neoplasms

NCT06299930 2024-03-08

Locoregional Recurrence After Neoadjuvant Versus Adjuvant Chemotherapy

10,328 enrolled

Breast Neoplasms

NCT06294054 2024-03-06

SELECT

707 enrolled

Genitourinary

Urinary Bladder Neoplasms, Genomic Instability

NCT06261138 2024-02-15

Survival Analysis: TACE vs. Combination Therapy in HCC

279 enrolled

Carcinoma, Hepatocellular

NCT06223763 2024-01-25

SUROVA

5,000 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT05273827 2024-01-05

Effect of Neoadjuvant Anti-PD-1 Immunotherapy on Perioperative Analgesia and Postoperative Delirium

81 enrolled

Agnosia, Delirium

NCT06151379 2023-11-30

Muscle Parameters and Pathological Response in Breast Cancer Patients

69 enrolled

Neoadjuvant Chemotherapy

NCT04902937 2023-11-28

CETC

Neoplastic Cells, Circulating

NCT06129812 2023-11-13

An Exploration of Candidates for Neoadjuvant Treatment in Resectable Pancreatic Cancer

1,132 enrolled

Pancreatic Neoplasms

NCT05912062 2023-09-29

BiOnHER

80 enrolled

Breast Neoplasms, Neoplasms

NCT06035250 2023-09-28

AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy

Stomach Neoplasms

NCT05974007 2023-08-03

NeoR-World

1,500 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05642104 2022-12-08

The Detection of Cell-in-cell Structure (CICs) in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy

175 enrolled

Breast Neoplasms

NCT05592873 2022-10-25

I-ONARC

317 enrolled

Rectal Neoplasms

NCT04926584 2022-08-16

KOMPASSneo

50 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05496270 2022-08-11

Surgery Alone Versus Neoadjuvant Treatment Followed by Surgery For MRI-defined T3 Mid-low Rectal Cancer

1,509 enrolled

Rectal Neoplasms

NCT05495308 2022-08-10

"Oncologic Results and Risk Factors for Recurrence in Patients With Locally Advanced Rectal Cancer and Pathologic Complete Response After Neoadjuvant Treatment. Results From an Observational Retrospective Multicenter Long-term Follow-up Study".

4 enrolled

Rectal Neoplasms

NCT04197076 2022-07-29

Neoadjuvant Therapy in Resectable Non-Small Cell Lung Cancer Stages IIB-IIIB

Carcinoma, Non-Small-Cell Lung

NCT04755907 2022-07-19

3D Bioprinted Models for Predicting Chemotherapy Response in Colorectal Cancer With/Without Liver Metastases

120 enrolled

Colorectal Neoplasms

NCT05441098 2022-07-01

Construction and Validation of an Assessment Model of PCR After NAT on Breast Cancer Patients With AI Technology

1,821 enrolled

Pathologic Complete Response, Breast Neoplasms

NCT05373810 2022-05-23

Registration Study Sarcoma

1,000 enrolled

Sarcoma

NCT05341479 2022-04-22

An Observational Study of Clinical Treatments for Patients With Oropharyngeal Carcinoma

Head & Neck

Oropharyngeal Neoplasms

NCT03699410 2021-10-13

LiBReCa

Terminated

25 enrolled

Locally Advanced Rectal Cancer

NCT04966975 2021-07-19

Effect and Prognosis of Immunohistochemical Biomarkers Changes in Patients With Bladder Cancer After Neoadjuvant Chemotherapy

60 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT04513457 2021-03-29

Chemotherapy for Resectable Colorectal Liver Metastases

967 enrolled

Liver Neoplasms, Colorectal Neoplasms

NCT02277938 2021-03-17

Acetylamantadine Excretion by Cancer Patients

120 enrolled

Tumor-Agnostic

Neoplasms

NCT04798976 2021-03-16

Personalized Evidence-based Treatment in Patients With Invasive Breast Cancer

3,000 enrolled

Breast Cancer-specific Survival

NCT04654195 2020-12-04

Study of ABCB1,SLC22A16 Drug Transporter Genes and Doxorubicin and Cyclophosphamide Toxicity in Brest Cancer Patient

100 enrolled

Breast Cancer Patients

NCT04581967 2020-10-09

Study of CYP2C19 and ALDH3A1 Polymorphisms in Breast Cancer Patients

100 enrolled